Gynecologic Cancer
Conference Coverage
Early biopsy predicts levonorgestrel IUD response in endometrial cancer
Endometrial pathology findings at 3 months predicted response to levonorgestrel-releasing IUD treatment for complex atypical hyperplasia or grade...
Commentary
High-grade cervical dysplasia in pregnancy
Pregnancy is a convenient time to capture women for cervical cancer screening given the increased contact with health care providers. Routine...
Conference Coverage
Study ranks risk factors for cervical cancer recurrence
Among patients with stage IB cervical cancer, deep stromal invasion and large tumor size are the factors associated with the greatest increased...
Conference Coverage
Younger age at diagnosis worsens cervical cancer prognosis
Being diagnosed with cervical cancer before the age of 40 was independently associated with worse overall survival, results from a single-center...
Conference Coverage
Skip lymphadenectomy if SLN mapping finds low-grade endometrial cancer
Lymphadenectomy is unnecessary if sentinel lymph node mapping successfully stages low-grade endometrial cancer, according to investigators from...
Conference Coverage
Nodal SUVmax on imaging may be prognostic biomarker in advanced cervical cancer
Primary tumor metabolic parameters were not significant prognostic factors for tumor recurrence in patients with regional lymph node–involved,...
Conference Coverage
Gynecologic cancer patients underutilize advance care directives
Gynecologic oncologists take heat for patients’ low rates of advance care directive planning.
Conference Coverage
Observation might be best in advanced-stage, low-grade ovarian CA
Think twice about adjuvant therapy.
News
Aspirin may improve survival in endometrial cancer
Low-dose aspirin use by endometrial cancer patients was associated with markedly reduced 5-year risks of disease progression and all-cause...
News
Bilateral sentinel lymph node biopsy safe alternative for assessing early cervical cancer
Key clinical point: Bilateral sentinel lymph node biopsy (BSLNB) alone is a safe alternative to bilateral pelvic lymphadenectomy (BPLND) for stage...
News
Farletuzumab may benefit patients with ovarian cancer and low CA-125 level
Key clinical point: Farletuzumab combined with carboplatin and taxane improved progression-free survival (PFS) and overall survival (OS) in...